Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, BFA, FVT

10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024


PLEASANTON, Calif., Jan. 24, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after market close on Thursday, February 15, 2024. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call.

Live audio of the webcast will be available on the "Investors" section of the company website at: www.10xgenomics.com. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts 
Investors: [email protected] 
Media: [email protected]

SOURCE 10x Genomics, Inc


These press releases may also interest you

at 07:15
Aerospike, Inc. ("Aerospike"), a leading database solutions provider, today announced the appointment of Venkatesh Guntur as the new Country Manager for Southeast Asia (ASEAN). In this strategic role, Venkatesh will spearhead Aerospike's business...

at 07:05
ACI Worldwide , a global leader in mission-critical, real-time payments software, today announced it has been recognized by U.S. News & World Report as one of the "Best Companies to Work For" in the 2024-25 edition of its annual rankings. This...

at 07:05
Today Luminar , a leading global automotive technology company, announced it is launching Sentinel1, its full-stack software suite, following five years of breakthrough developments in Software and AI systems. The Sentinel solution enables automakers...

at 07:05
Checkmarx, the industry leader in cloud-native application security for the enterprise, and Wiz, a forefront provider of cloud security solutions, are pleased to announce an extended partnership to further enrich the Wiz platform. This enhancement...

at 07:05
Natera, Inc. , a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that its latest research and data on prenatal and reproductive genetics will be presented at the 28th International Conference on Prenatal Diagnosis and...

at 07:00
Dayforce, Inc. , a global human capital management (HCM) leader that makes work life better, today announced that WHSmith, a leading global retailer for news, books, and convenience, has expanded its use of the Dayforce platform. WHSmith has...



News published on and distributed by: